Kestra Medical Technologies Ltd. (KMTS)
28.68
+3.21
(+12.60%)
USD |
NASDAQ |
Oct 15, 16:00
29.10
+0.42
(+1.46%)
Pre-Market: 20:00
Kestra Medical Technologies Research and Development Expense (Quarterly) : 6.796M for July 31, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 6.796M |
| April 30, 2026 | 5.634M |
| January 31, 2026 | 4.972M |
| October 31, 2025 | 4.878M |
| July 31, 2025 | 4.001M |
| April 30, 2025 | 5.386M |
| January 31, 2025 | 3.353M |
| Date | Value |
|---|---|
| October 31, 2024 | 3.509M |
| July 31, 2024 | 3.404M |
| April 30, 2024 | 3.821M |
| January 31, 2024 | 3.735M |
| October 31, 2023 | 4.199M |
| July 31, 2023 | 3.735M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Rockwell Medical, Inc. | 0.04M |
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |
| ResMed, Inc. | 105.73M |